187 related articles for article (PubMed ID: 31788561)
1. Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study.
Musiimenta A; Tumuhimbise W; Mugaba AT; Muzoora C; Armstrong-Hough M; Bangsberg D; Davis JL; Haberer JE
J Clin Tuberc Other Mycobact Dis; 2019 Dec; 17():100119. PubMed ID: 31788561
[TBL] [Abstract][Full Text] [Related]
2. Digital Adherence Technologies and Mobile Money Incentives for Management of Tuberculosis Medication Among People Living With Tuberculosis: Mixed Methods Formative Study.
Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
JMIR Form Res; 2023 Apr; 7():e45301. PubMed ID: 37043263
[TBL] [Abstract][Full Text] [Related]
3. Digital Adherence Technologies Linked to Mobile Money Incentives for Medication Adherence Among People Living With Tuberculosis: Mixed Methods Feasibility and Acceptability Study.
Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
JMIR Hum Factors; 2024 May; 11():e47996. PubMed ID: 38819905
[TBL] [Abstract][Full Text] [Related]
4. Mobile Health Technologies May Be Acceptable Tools for Providing Social Support to Tuberculosis Patients in Rural Uganda: A Parallel Mixed-Method Study.
Musiimenta A; Tumuhimbise W; Atukunda EC; Mugaba AT; Muzoora C; Armstrong-Hough M; Bangsberg D; Davis JL; Haberer JE
Tuberc Res Treat; 2020; 2020():7401045. PubMed ID: 31969998
[TBL] [Abstract][Full Text] [Related]
5. The feasibility, acceptability, and preliminary impact of real-time monitors and SMS on tuberculosis medication adherence in southwestern Uganda: Findings from a mixed methods pilot randomized controlled trial.
Musiimenta A; Tumuhimbise W; Atukunda EC; Mugaba AT; Musinguzi N; Muzoora C; Bangsberg D; Davis JL; Haberer JE
PLOS Glob Public Health; 2023; 3(12):e0001813. PubMed ID: 38051699
[TBL] [Abstract][Full Text] [Related]
6. Acceptability and Feasibility of Real-Time Antiretroviral Therapy Adherence Interventions in Rural Uganda: Mixed-Method Pilot Randomized Controlled Trial.
Musiimenta A; Atukunda EC; Tumuhimbise W; Pisarski EE; Tam M; Wyatt MA; Ware NC; Haberer JE
JMIR Mhealth Uhealth; 2018 May; 6(5):e122. PubMed ID: 29773527
[TBL] [Abstract][Full Text] [Related]
7. Acceptability, Usefulness, and Ease of Use of an Enhanced Video Directly Observed Treatment System for Supporting Patients With Tuberculosis in Kampala, Uganda: Explanatory Qualitative Study.
Sekandi JN; McDonald A; Nakkonde D; Zalwango S; Kasiita V; Kaggwa P; Kakaire R; Atuyambe L; Buregyeya E
JMIR Form Res; 2023 Nov; 7():e46203. PubMed ID: 37948121
[TBL] [Abstract][Full Text] [Related]
8. Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials.
Ridho A; Alfian SD; van Boven JFM; Levita J; Yalcin EA; Le L; Alffenaar JW; Hak E; Abdulah R; Pradipta IS
J Med Internet Res; 2022 Feb; 24(2):e33062. PubMed ID: 35195534
[TBL] [Abstract][Full Text] [Related]
9. Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.
Anenmose Maro R; Mtenga A; Mtesha B; Wilhelm K; Lekashingo N; Sumari-de Boer M; Ngowi K
J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100409. PubMed ID: 38225942
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.
Mtenga AE; Maro RA; Dillip A; Msoka P; Emmanuel N; Ngowi K; Sumari-de Boer M
Online J Public Health Inform; 2024 Jun; 16():e51662. PubMed ID: 38922643
[TBL] [Abstract][Full Text] [Related]
11. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.
Subbaraman R; de Mondesert L; Musiimenta A; Pai M; Mayer KH; Thomas BE; Haberer J
BMJ Glob Health; 2018; 3(5):e001018. PubMed ID: 30364330
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa.
Mukora R; Ahumah B; Maraba N; Orrell C; Jennings L; Naidoo P; Fielding KL; Velen K; Charalambous S; Chetty-Makkan CM
PLOS Glob Public Health; 2023; 3(10):e0001885. PubMed ID: 37889875
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
[TBL] [Abstract][Full Text] [Related]
14. Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
Leddy A; Ggita J; Berger CA; Kityamuwesi A; Sanyu AN; Tinka LK; Crowder R; Turyahabwe S; Katamba A; Cattamanchi A
J Med Internet Res; 2023 May; 25():e38828. PubMed ID: 37252774
[TBL] [Abstract][Full Text] [Related]
15. Stakeholders' Perceptions of Benefits of and Barriers to Using Video-Observed Treatment for Monitoring Patients With Tuberculosis in Uganda: Exploratory Qualitative Study.
Sekandi JN; Kasiita V; Onuoha NA; Zalwango S; Nakkonde D; Kaawa-Mafigiri D; Turinawe J; Kakaire R; Davis-Olwell P; Atuyambe L; Buregyeya E
JMIR Mhealth Uhealth; 2021 Oct; 9(10):e27131. PubMed ID: 34704961
[TBL] [Abstract][Full Text] [Related]
16. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
17. How Integrated Digital Tools Can Improve Tuberculosis Medication Adherence: A Longitudinal Study in China.
Wang X; Fu Q; Zhou M; Li Y
Telemed J E Health; 2024 Feb; 30(2):490-498. PubMed ID: 37498525
[No Abstract] [Full Text] [Related]
18. Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial.
Sekandi JN; Onuoha NA; Buregyeya E; Zalwango S; Kaggwa PE; Nakkonde D; Kakaire R; Atuyambe L; Whalen CC; Dobbin KK
JMIR Res Protoc; 2021 Jan; 10(1):e18029. PubMed ID: 32990629
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.
Liu X; Lewis JJ; Zhang H; Lu W; Zhang S; Zheng G; Bai L; Li J; Li X; Chen H; Liu M; Chen R; Chi J; Lu J; Huan S; Cheng S; Wang L; Jiang S; Chin DP; Fielding KL
PLoS Med; 2015 Sep; 12(9):e1001876. PubMed ID: 26372470
[TBL] [Abstract][Full Text] [Related]
20. Perceptions and acceptability of short message services technology to improve treatment adherence amongst tuberculosis patients in Peru: a Focus Group Study.
Albino S; Tabb KM; Requena D; Egoavil M; Pineros-Leano MF; Zunt JR; García PJ
PLoS One; 2014; 9(5):e95770. PubMed ID: 24828031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
